MedPath

ong-term outcome after heparin plus edoxaban versus heparin plus vitamin K antagonists for acute deep vein thrombosis and pulmonary embolism

Completed
Conditions
kwaliteit van leven
embolism
thrombosis
10037454
10014523
Registration Number
NL-OMON42861
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
255
Inclusion Criteria

Patients from centers that participated in the Hokusai VTE trial and where implementation of this study is feasible.

Exclusion Criteria

Inability for follow-up due to geographic or logistic reasons, or death.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath